Molina Healthcare (MOH) – Analysts’ Recent Ratings Updates

A number of research firms have changed their ratings and price targets for Molina Healthcare (NYSE: MOH):

• 10/27/2026 – Molina Healthcare had its “outperform” rating reaffirmed by Sanford C. Bernstein.
• 10/27/2026 – Molina Healthcare had its price target raised by JPMorgan Chase & Co. from $220.00 to $225.00. They now have a “neutral” rating on the stock.
• 10/26/2026 – Molina Healthcare had its “hold” rating reaffirmed by Deutsche Bank Aktiengesellschaft. They now have a $163.00 price target on the stock.
• 10/24/2026 – Molina Healthcare was upgraded by Wall Street Zen from “sell” to “hold”.
• 10/23/2026 – Molina Healthcare had its price target raised by Royal Bank Of Canada from $218.00 to $222.00. They now have a “sector perform” rating on the stock.
• 10/23/2026 – Molina Healthcare was given a new $198.00 price target by Robert W. Baird.
• 10/23/2026 – Molina Healthcare had its price target raised by UBS Group from $202.00 to $225.00. They now have a “neutral” rating on the stock.
• 10/23/2026 – Molina Healthcare had its price target lowered by Barclays from $180.00 to $178.00. They now have an “underweight” rating on the stock.
• 10/23/2026 – Molina Healthcare was given a new $255.00 price target by Mizuho.
• 10/23/2026 – Molina Healthcare had its “hold” rating reaffirmed by Jefferies Financial Group. They now have a $220.00 price target on the stock.
• 10/23/2026 – Molina Healthcare had its price target raised by Morgan Stanley from $167.00 to $192.00. They now have an “equal weight” rating on the stock.
• 10/21/2026 – Molina Healthcare was upgraded by Weiss Ratings from “sell (d)” to “sell (d+)”.
• 10/12/2026 – Molina Healthcare was downgraded by Zacks Research from “strong-buy” to “hold”.
• 10/9/2026 – Molina Healthcare had its “neutral” rating reaffirmed by Cantor Fitzgerald.
• 10/6/2026 – Molina Healthcare was downgraded by Weiss Ratings from “sell (d+)” to “sell (d)”.
• 10/4/2026 – Molina Healthcare was downgraded by Wall Street Zen from “hold” to “sell”.
• 9/26/2026 – Molina Healthcare was upgraded by Wall Street Zen from “sell” to “hold”.
• 9/22/2026 – Molina Healthcare was upgraded by Zacks Research from “hold” to “strong-buy”.
• 9/11/2026 – Molina Healthcare was upgraded by Weiss Ratings from “sell (d)” to “sell (d+)”.
• 9/4/2026 – Molina Healthcare had its “neutral” rating reaffirmed by Cantor Fitzgerald.

Molina Healthcare Trading Up 0.1%

Molina Healthcare stock traded up $0.17 during trading on Tuesday, reaching $208.62. The company had a trading volume of 313,562 shares, compared to its average volume of 1,272,404. The company has a debt-to-equity ratio of 0.95, a quick ratio of 1.69 and a current ratio of 1.69. The firm has a market capitalization of $10.89 billion, a price-to-earnings ratio of -217.31, a PEG ratio of 11.69 and a beta of 0.74. Molina Healthcare, Inc has a 12-month low of $121.06 and a 12-month high of $244.89. The stock’s 50 day moving average price is $200.78 and its two-hundred day moving average price is $184.94.

Molina Healthcare (NYSE:MOH) last posted its quarterly earnings results on Wednesday, October 21st. The company reported $0.89 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.79 by $0.10. The firm had revenue of $11.08 billion during the quarter, compared to the consensus estimate of $10.86 billion. Molina Healthcare had a positive return on equity of 2.50% and a negative net margin of 0.11%. The firm’s quarterly revenue was down 3.4% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.84 earnings per share. As a group, equities analysts expect that Molina Healthcare, Inc will post 5.30 earnings per share for the current fiscal year.

Molina Healthcare, Inc is a managed-care company that provides health insurance and related services primarily through government-sponsored programs. Its offerings include Medicaid, Medicare, Medicare-Medicaid dual-eligible plans and health plans sold through government marketplaces under the Affordable Care Act.

The company’s services generally include medical care coordination, behavioral health support, pharmacy benefits and, depending on the plan and state, dental and vision benefits.